BioNTech SE vaccine candidates (RNA vaccine candidates for SARS-CoV-2 variants)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BioNTech SE vaccine candidates (RNA vaccine candidates for SARS-CoV-2 variants), covering 2026-04-28 to 2026-04-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals [Phase 2, Phase 3]